bit.bio raises $30 million led by M&G Investments

bit.bio, the global leader in cell programming technology, today announced the successful closing of a $30 million financing round led by M&G Investments, a leading international savings and investment company.

Artificial intelligence predicts tongue disease with 96 percent accuracy

A novel system that uses machine learning to predict tongue disease.

August 15, 2024

Light Horse emerges with $62m and Novartis partnership worth up to $1bn – Pharmaceutical Technology

Light Horse pursues a function-first approach with its genetic editing-based platform. Image credit: Shutterstock/ Hyejin Kang. Light Horse Therapeutics has galloped on to the biotech

January 10, 2025

EMTALA, a vital health law you’ve never heard of, is in danger

Anyone who has gone to a hospital’s emergency room expecting to receive medical care — not knowing where else to turn, uncertain whether a loved

April 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.